Recursion Pharmaceuticals Inc (RXRX)
6.63
+0.23
(+3.59%)
USD |
NASDAQ |
Nov 04, 16:00
6.64
+0.01
(+0.15%)
After-Hours: 20:00
Recursion Pharmaceuticals Price: 6.63 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 01, 2024 | 6.36 | 6.58 | 6.335 | 6.40 | 3.624M |
| Oct 31, 2024 | 6.65 | 6.685 | 6.32 | 6.32 | 4.378M |
| Oct 30, 2024 | 6.62 | 6.90 | 6.60 | 6.68 | 4.475M |
| Oct 29, 2024 | 6.85 | 6.85 | 6.65 | 6.74 | 2.507M |
| Oct 28, 2024 | 6.58 | 6.945 | 6.56 | 6.87 | 4.547M |
| Oct 25, 2024 | 6.42 | 6.61 | 6.28 | 6.48 | 3.518M |
| Oct 24, 2024 | 6.45 | 6.45 | 6.195 | 6.36 | 2.934M |
| Oct 23, 2024 | 6.55 | 6.63 | 6.24 | 6.33 | 3.977M |
| Oct 22, 2024 | 6.70 | 6.79 | 6.56 | 6.61 | 2.844M |
| Oct 21, 2024 | 6.935 | 6.94 | 6.590 | 6.76 | 3.966M |
| Oct 18, 2024 | 6.57 | 6.95 | 6.57 | 6.94 | 3.634M |
| Oct 17, 2024 | 7.10 | 7.10 | 6.54 | 6.55 | 4.857M |
| Oct 16, 2024 | 6.75 | 7.07 | 6.71 | 7.01 | 4.525M |
| Oct 15, 2024 | 6.72 | 6.766 | 6.49 | 6.67 | 2.580M |
| Oct 14, 2024 | 6.64 | 6.81 | 6.515 | 6.72 | 3.609M |
| Oct 11, 2024 | 6.11 | 6.67 | 6.06 | 6.62 | 5.396M |
| Oct 10, 2024 | 6.09 | 6.21 | 5.95 | 6.18 | 4.984M |
| Oct 09, 2024 | 6.49 | 6.63 | 6.09 | 6.15 | 5.736M |
| Oct 08, 2024 | 6.18 | 6.49 | 6.14 | 6.44 | 3.771M |
| Oct 07, 2024 | 6.12 | 6.19 | 6.03 | 6.18 | 3.492M |
| Oct 04, 2024 | 6.15 | 6.34 | 6.07 | 6.11 | 3.848M |
| Oct 03, 2024 | 6.08 | 6.18 | 6.04 | 6.06 | 4.308M |
| Oct 02, 2024 | 6.19 | 6.41 | 6.07 | 6.11 | 4.764M |
| Oct 01, 2024 | 6.51 | 6.58 | 6.07 | 6.17 | 7.273M |
| Sep 30, 2024 | 6.89 | 7.095 | 6.59 | 6.59 | 5.325M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.56
Minimum
May 02 2023
41.33
Maximum
Jul 13 2021
12.04
Average
9.01
Median
Jun 06 2024
Price Benchmarks
| Eli Lilly and Co | 806.23 |
| Pfizer Inc | 27.76 |
| Revance Therapeutics Inc | 5.80 |
| Twist Bioscience Corp | 42.03 |
| NovaBay Pharmaceuticals Inc | 0.78 |
Price Related Metrics
| PS Ratio | 31.18 |
| PEG Ratio | -0.2145 |
| Price to Book Value | 3.202 |
| Earnings Yield | -24.74% |
| Market Cap | 1.871B |
| PEGY Ratio | -0.2145 |